export const antiMicrobialDrugsData = {
  name: "Anti-Microbial Drugs",
  subtopics: {
    essay: {
      name: "Essay",
      questions: [
        "Anti-Amoebic Drugs ******* (Jul 23;Aug 13;Aug 11;Feb 09;Aug 07;Aug 04;Nov 93) (Pg.No: 893)\n- Metronidazole, Mechanism of Action, Spectrum of Activity, Uses",
        "Anti-Malarial drugs ***** (Aug 17;Aug 14;Aug 08;Oct 03;Jan 93) (Pg.No: 877)\n- Classification, Chloroquine Resistant Malaria, Extramalarial uses\n- Classification, ACT Prophylaxis\n- Classification, Chloroquine, Mechanism of Action, Adverse Drug Reactions, Uses",
        "Anti-tubercular drugs (or) Treatment of Tuberculosis ***** (Jul 23;Aug 16;Feb 11;Feb 10;Feb 08) (Pg.No: 816)\n- Classification, Isoniazid, Mechanism of Action, Adverse Drug Reactions, Short Course Treatment of TB\n- Rifampicin, Mechanism of Action, Adverse Drug Reactions, Uses\n- Mechanism of Action, Adverse Drug Reactions of Any 1 Drug\n- Treatment of Pulmonary TB, Bacterial Resistance\n- Mechanism of Action, Adverse Drug Reactions of Any 2 Drugs\nProbable Cases:\n- A 25 year old male came with complaints of cough with expectoration, evening rise of temperature, sweating and loss of appetite for past 2 weeks",
        "Anti-Fungal agents *** (Feb 20;Feb 15;Aug 12) (Pg.No: 838)\n- Classification, Imidazoles: Mechanism of Action, Ketoconazole: Uses and Adverse Drug Reactions\n- Classification, Fluconazole, Mechanism of Action, Adverse Drug Reactions, Pharmacokinetics, Therapeutic Uses\n- Classification, Griseofulvin, Mechanism of Action, Adverse Drug Reactions, Drug Interactions, Therapeutic Uses",
        "Anti-Leprosy Drugs *** (Feb 07;Apr 98;Nov 94) (Pg.No: 831)\n- Multidrug Therapy, Therapeutic Aspects and Adverse Effects of 3 drugs used\n- Enumerate Drugs used in Leprosy, Dosage Schedule and Adverse Effects of drugs used in Paucibacillary and Multi-bacillary Leprosy, Treatment of Lepra Reaction",
        "Beta Lactam Antibiotics *** (Feb 19;Feb 16;Aug 04) (Pg.No: 766)\n- Classification of Beta Lactam Antibiotics, Mechanism of Action, Adverse Drug Reactions, Uses of Penicillin, Penicillin G, Beta Lactamase Inhibitors and their uses",
        "Fluoroquinolones *** (Feb 13;Oct 96;Nov 94) (Pg.No: 760)\n- Classification, Mechanism of Action, Uses, 2nd Generation Fluoroquinolones",
        "Penicillins *** (Feb 09;Aug 04;Oct 98) (Pg.No: 766)\n- Classification, Penicillin G, Mechanism of Action, Uses, Preparations,\nComparison Pharmacokinetics of Aminopenicillins and Penicillin G\n- Classification, Ampicillin, Mechanism of Action, Adverse Drug Reactions, Uses\n- Classification, Aminopenicillin, Mechanism of Action, Uses, Adverse Drug Reactions\n- Classification, Penicillin G, Mechanism of Action, Uses, Adverse Drug Reactions",
        "Aminoglycosides ** (Jul 23;Aug 09) (Pg.No: 793)\n- Classification, Mechanism of Action, Adverse Drug Reactions, Uses,\nPharmacokinetics\n- Classification, Mechanism of Action, Adverse Drug Reactions, Uses of Gentamycin",
        "Broad Spectrum Antibiotics ** (Mar 02;Oct 00) (Pg.No: 784)\n- Classification of Tetracyclines, Mechanism of Action, Adverse Drug Reactions, Antibacterial Spectrum\n- Why Tetracycline is not used in Children, Precautions to be taken before use of Tetracycline",
        "Cephalosporins ** (Aug 15;Apr 01) (Pg.No: 775)\n- Classification, Spectrum of 3rd Generation Cephalosporins, Drug Therapy in Bacterial Meningitis, Chemoprophylaxis of Meningitis\n- Classification, Mechanism of Action, Adverse Drug Reactions, Uses, Post Antibiotic Effect",
        "Antivirals (Feb 08) (Pg.No: 849)\n- Classification, Acyclovir, Mechanism of Action, Adverse Drug Reactions, Uses",
        "Drugs for Treatment of Typhoid (Feb 23) (Pg.No: 762)\n- Ciprofloxacin, Mechanism of Action, Adverse Drug Reactions, Uses, Treatment of Ciprofloxacin Resistant Cases\nProbable Cases:\n- A 15 year old girl admitted with complaints of high fever, head ache and stomach pain. She revealed that she had visited marina beach last week end and ate from roadside food stall",
        "Macrolides (Aug 08) (Pg.No: 801)\n- Classification, Erythromycin, Mechanism of Action, Adverse Drug Reactions, Uses",
        "Multi-Drug-Resistant Tuberculosis (MDR-TB) (Feb 22) (Pg.No: 825)\n- Anti-Tubercular Therapy (ATT) in MDR TB, Mechanism of Action and Adverse Effects, Categories of Treatment in MDR TB, Interactions of ATT drugs and Oral Contraceptives (OCPs) and its Management\n- Classification of ATT, Directly Observed Treatment, Short Course Chemotherapy (DOTS), Management of MDR TB"
      ]
    },
    "short-note": {
      name: "Short Note",
      questions: [
        "Metronidazole ********* (Aug 22;Sep 21;Feb 11;Aug 10;Oct 03;Apr 00;Apr 98;Oct 96;Nov 94) (Pg.No: 894)",
        "3rd Generation Cephalosporins ******* (Dec 23;Nov 20;Aug 09;Feb 08;Aug 05;Oct 00;Apr 99) (Pg.No: 777)",
        "Albendazole ****** (Feb 14;Aug 13;Aug 05;Feb 05;Oct 03;Oct 00) (Pg.No: 908)",
        "Aminoglycosides ***** (Mar 22;Feb 18;Aug 15;Aug 08;Aug 06) (Pg.No: 793)\n- Mechanism of Action, Adverse Drug Reactions",
        "Amphotericin B ***** (Jul 23;Mar 22;Feb 22;Aug 14;Nov 93) (Pg.No: 839)\n- Therapeutic Uses\n- New Formulations",
        "Lepra reaction ***** (Feb 23;Aug 22;Feb 15;Feb 13;Oct 03) (Pg.No: 837)\n- Management",
        "Short Course Chemotherapy in Treatment of Tuberculosis ***** (Feb 20;Feb 19;Aug 14;Oct 96;Apr 96) (Pg.No: 824)",
        "Anti Retroviral Drugs **** (Aug 08;Feb 06;Mar 02;Oct 00) (Pg.No: 860)",
        "Bacterial Drug Resistance **** (Feb 11;Feb 10;Feb 06;Oct 03) (Pg.No: 742)",
        "Chloroquine **** (Feb 23;Feb 10;Feb 08;Aug 04) (Pg.No: 879)",
        "Cotrimoxazole **** (Sep 21;Aug 15;Aug 05;Nov 93) (Pg.No: 757)\n- Rationale in Use\n- Mechanism of Action, Adverse Drug Reactions, Uses",
        "Rifampicin **** (Dec 23;Feb 09;Oct 98;Dec 91) (Pg.No: 818)",
        "Artemisinin Combination Therapy *** (Aug 15;Feb 14;Aug 05) (Pg.No: 889)\n- Advantages, Pharmacological Basis of Artemisinin Derivatives in Malaria",
        "Chemoprophylaxis of Latent Tubercular Infections *** (Nov 20;Aug 09;Apr 00) (Pg.No: 828)\n- Definition, Examples with Rationale",
        "Dapsone *** (Aug 18;Aug 14;Feb 08) (Pg.No: 831)\n- Sulfone syndrome",
        "Gentamicin *** (Aug 12;Feb 05;Nov 01) (Pg.No: 797)",
        "Mebendazole *** (Feb 15;Aug 09;Oct 97) (Pg.No: 906)\n- Indications\n- Mechanism of Action, Adverse Drug Reactions",
        "Nucleoside Reverse Transcriptase Inhibitors *** (Feb 19;Feb 07;Apr 97) (Pg.No: 861)",
        "Vancomycin *** (Jul 23;Aug 22;Aug 13) (Pg.No: 806)",
        "Acyclovir ** (Feb 23;Aug 19) (Pg.No: 850)",
        "Azithromycin ** (Aug 17;Aug 12) (Pg.No: 804)\n- Antibacterial Spectrum, Mechanism of Action, Adverse Drug Reactions, Uses",
        "Beta Lactamase Inhibitions ** (Mar 22;Feb 22) (Pg.No: 774)",
        "Ciprofloxacin ** (Mar 22;Aug 04) (Pg.No: 760)\n- Mechanism of Action, Uses\n- Why Ciprofloxacin is Contraindicated in Children less than 8 years of age",
        "Clarithromycin ** (Feb 11;Feb 09) (Pg.No: 803)",
        "Clofazimine ** (Aug 12;Aug 10) (Pg.No: 832)\n- Rationale in Lepra Reaction",
        "Erythromycin ** (Feb 20;Oct 03) (Pg.No: 801)",
        "Extramalarial uses of Chloroquine ** (Feb 11;Aug 09) (Pg.No: 879)",
        "Fluoroquinolones ** (Aug 08;Nov 94) (Volume 2, Pg.No: 760)",
        "Highly Active Anti-Retroviral Therapy (HAART) ** (Aug 22;Aug 19) (Pg.No: 868)",
        "Imipenem ** (Feb 15;Feb 13) (Pg.No: 782)",
        "Isoniazid ** (Aug 10;Aug 05) (Pg.No: 816)",
        "Ivermectin ** (Jul 23;Feb 11) (Pg.No: 911)",
        "Mefloquine ** (Mar 02;Oct 00) (Pg.No: 881)",
        "Post-Exposure Prophylaxis (PEP) of HIV infection ** (Jul 23;Aug 14) (Pg.No: 871)",
        "Praziquantel ** (Aug 06;Apr 01) (Pg.No: 912)",
        "Primaquine ** (Aug 10;Feb 09) (Pg.No: 885)",
        "Semisynthetic Penicillins ** (Feb 13;Feb 05) (Pg.No: 770)",
        "Topical Anti-Fungal Agents ** (Feb 13;Aug 07) (Pg.No: 847)",
        "Treatment of Urinary Tract Infections (UTI) ** (Feb 23;Feb 08) (Pg.No: 810)",
        "4th generation Cephalosporins (Feb 14) (Pg.No: 779)",
        "Amikacin (Feb 10) (Pg.No: 799)",
        "Anti-Pseudomonal Penicillins (or) Piperacillin (Aug 14) (Pg.No: 774)",
        "Broad Spectrum Penicillins (Aug 06) (Pg.No: 772)",
        "Cephalosporins (Dec 90) (Pg.No: 775)",
        "Diethylcarbamazine Citrate (DEC) (Aug 11) (Pg.No: 910)",
        "Doxycycline (Feb 10) (Pg.No: 787)",
        "Drugs in Typhoid fever (Aug 11) (Pg.No: 762)",
        "Drugs used in Syphilis (Feb 08) (Pg.No: 766)",
        "Erythrocytic Schizonticidal Agents (Aug 12) (Pg.No: 876)",
        "Fluconazole (Feb 10) (Pg.No: 844)\n- Uses\n- Advantage over ketoconazole",
        "Fusion Inhibitors in HIV infections (Aug 12) (Pg.No: 867)",
        "Ketoconazole (Aug 10) (Pg.No: 844)",
        "Management of Cerebral Malaria (Aug 10) (Pg.No: 883)",
        "Management of Chloroquine Resistant Malaria (Feb 06) (Pg.No: 877)",
        "Meropenem (Aug 12) (Pg.No: 782)",
        "Multi-Drug-Resistant Tuberculosis (MDR-TB) (Mar 22) (Pg.No: 825)",
        "Newer Macrolides (Feb 13) (Pg.No: 803)",
        "Principles and Guidelines in Treatment of HIV (Aug 18) (Pg.No: 867)",
        "Pyrantel Pamoate (Nov 01) (Pg.No: 909)",
        "Pyrazinamide (Aug 11) (Pg.No: 819)",
        "Quinine (Feb 09) (Pg.No: 882)",
        "Repository Preparations of Penicillin (Aug 09) (Pg.No: 769)",
        "Retroviral Protease Inhibitors and Combination Therapy (Sep 21) (Pg.No: 864)",
        "Role of Corticosteroids in Management of Tuberculosis (Aug 13) (Pg.No: 828)",
        "Terbinafine (Feb 18) (Pg.No: 847)",
        "Therapeutic Uses of Amoxycillin (Apr 98) (Pg.No: 773)",
        "Topical Sulphonamides (Aug 09) (Pg.No: 756)"
      ]
    }
  }
};